317 related articles for article (PubMed ID: 26110221)
21. An investigation of an open-access model for scaling up methadone maintenance treatment.
Madden LM; Farnum SO; Eggert KF; Quanbeck AR; Freeman RM; Ball SA; Schottenfeld RS; Shi JM; Savage ME; Barry DT
Addiction; 2018 Aug; 113(8):1450-1458. PubMed ID: 29453891
[TBL] [Abstract][Full Text] [Related]
22. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
23. Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.
Soyka M; Träder A; Klotsche J; Backmund M; Bühringer G; Rehm J; Wittchen HU
J Clin Psychopharmacol; 2011 Oct; 31(5):678-80. PubMed ID: 21881461
[No Abstract] [Full Text] [Related]
24. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
Kahan M; Sutton N
Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
[TBL] [Abstract][Full Text] [Related]
25. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
Lua PL; Talib NS
Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
[TBL] [Abstract][Full Text] [Related]
26. Methadone therapy for opioid dependence.
Krambeer LL; von McKnelly W; Gabrielli WF; Penick EC
Am Fam Physician; 2001 Jun; 63(12):2404-10. PubMed ID: 11430455
[TBL] [Abstract][Full Text] [Related]
27. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
28. Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
Newman RG; Gevertz SG
J Addict Dis; 2011 Oct; 30(4):318-22. PubMed ID: 22026523
[No Abstract] [Full Text] [Related]
29. Buprenorphine unobserved "home" induction: a survey of Ontario's addiction physicians.
Srivastava A; Kahan M; Leece P; McAndrew A
Addict Sci Clin Pract; 2019 May; 14(1):18. PubMed ID: 31039821
[TBL] [Abstract][Full Text] [Related]
30. Methadone as social control: institutionalized stigma and the prospect of recovery.
Harris J; McElrath K
Qual Health Res; 2012 Jun; 22(6):810-24. PubMed ID: 22232295
[TBL] [Abstract][Full Text] [Related]
31. Treatment options for opiate addiction.
J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
[No Abstract] [Full Text] [Related]
32. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
[TBL] [Abstract][Full Text] [Related]
33. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
34. Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol.
Bawor M; Dennis BB; Anglin R; Steiner M; Thabane L; Samaan Z
Syst Rev; 2014 May; 3():45. PubMed ID: 24887111
[TBL] [Abstract][Full Text] [Related]
35. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.
Strang J; Manning V; Mayet S; Ridge G; Best D; Sheridan J
Addiction; 2007 May; 102(5):761-70. PubMed ID: 17506153
[TBL] [Abstract][Full Text] [Related]
36. Maintenance for opioid addiction with buprenorphine and methadone: "The only thing new in the world is the history you don't know".
Stimmel B
J Addict Dis; 2005; 24(3):1-6. PubMed ID: 16186079
[No Abstract] [Full Text] [Related]
37. Methadone maintenance in primary care: a randomized controlled trial.
Fiellin DA; O'Connor PG; Chawarski M; Pakes JP; Pantalon MV; Schottenfeld RS
JAMA; 2001 Oct; 286(14):1724-31. PubMed ID: 11594897
[TBL] [Abstract][Full Text] [Related]
38. Opioid substitution therapy: Lowering the treatment thresholds.
Kourounis G; Richards BD; Kyprianou E; Symeonidou E; Malliori MM; Samartzis L
Drug Alcohol Depend; 2016 Apr; 161():1-8. PubMed ID: 26832931
[TBL] [Abstract][Full Text] [Related]
39. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
[TBL] [Abstract][Full Text] [Related]
40. The science and practice of medication-assisted treatments for opioid dependence.
Pecoraro A; Ma M; Woody GE
Subst Use Misuse; 2012; 47(8-9):1026-40. PubMed ID: 22676570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
